Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
1-15 of 229
Improving Migraine Diagnosis in Vulnerable Populations
NeuroFrontiersImproving Migraine Diagnosis in Vulnerable Populations
Juliana VanderPluym, MD
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
NeuroFrontiersUnderstanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
Juliana VanderPluym, MD
Rethinking Vestibular Migraine in Clinical Practice
NeuroFrontiersRethinking Vestibular Migraine in Clinical Practice
Insights on Migraine Care Disparities from OVERCOME
AudioAbstractsInsights on Migraine Care Disparities from OVERCOME
Ryan Quigley
Shradha Kakde, MBBS
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
NeuroFrontiersVagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
- advertisement
The Role of CGRPs in First-Line Preventive Migraine Therapy
NeuroFrontiersThe Role of CGRPs in First-Line Preventive Migraine Therapy
Charles Turck, PharmD, BCPS, BCCCP
Richard B. Lipton, MD
Hope O'Brien, MD, MBA, FAHS, FAAN
The Recovery Trajectory of Subarachnoid Hemorrhage
NeuroFrontiersThe Recovery Trajectory of Subarachnoid Hemorrhage
Jay Max Findlay
The Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
NeuroFrontiersThe Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
Jay Max Findlay
Spotting the Warning Signs of Subarachnoid Hemorrhage
NeuroFrontiersSpotting the Warning Signs of Subarachnoid Hemorrhage
Jay Max Findlay
Evaluating Delayed Presentations of Subarachnoid Hemorrhage
NeuroFrontiersEvaluating Delayed Presentations of Subarachnoid Hemorrhage
Jay Max Findlay
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
NeuroFrontiersConsensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
- advertisement
Mobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
NeuroFrontiersMobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
How Real-World Adherence Is Shaping Preventive Migraine Treatment
NeuroFrontiersHow Real-World Adherence Is Shaping Preventive Migraine Treatment
Alexandria May, PharmD, BCPS
Jessica Ailani, MD, FAHS, FAAN, FANA
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
NeuroFrontiersRecognizing TK2d: Key Clinical Signs and Diagnostic Protocols
Alexandria May, PharmD, BCPS
Kaitlin Batley, MD
